These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26164836)

  • 61. Efficacy of topical calcineurin inhibitors in psoriasis.
    Wang C; Lin A
    J Cutan Med Surg; 2014; 18(1):8-14. PubMed ID: 24377467
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis.
    Jegasothy BV; Ackerman CD; Todo S; Fung JJ; Abu-Elmagd K; Starzl TE
    Arch Dermatol; 1992 Jun; 128(6):781-5. PubMed ID: 1376102
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tacrolimus ointment 0.1% for the treatment of peristomal skin disease: 3 case reports.
    Wells GL; Brown J; Manganiello WD; Chapman MS
    Cutis; 2006 Oct; 78(4):258-60. PubMed ID: 17121062
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Early treatment of multiple and spreading lichen striatus with topical tacrolimus.
    Jo JH; Jang HS; Park HJ; Kim MB; Oh CK; Kwon KS
    J Am Acad Dermatol; 2007 Nov; 57(5):904-5. PubMed ID: 17939946
    [No Abstract]   [Full Text] [Related]  

  • 65. Topical tacrolimus treatment for localized pretibial bullous phemphigoid.
    Calcaterra R; Carducci M; Franco G; Mussi A; Morrone A
    J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):177-9. PubMed ID: 18410329
    [No Abstract]   [Full Text] [Related]  

  • 66. Clinical observations of the treatment of canine perianal fistulas with topical tacrolimus in 10 dogs.
    Misseghers BS; Binnington AG; Mathews KA
    Can Vet J; 2000 Aug; 41(8):623-7. PubMed ID: 10945128
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Topical tacrolimus for facial psoriasis.
    Clayton TH; Harrison PV; Nicholls R; Delap M
    Br J Dermatol; 2003 Aug; 149(2):419-20. PubMed ID: 12932257
    [No Abstract]   [Full Text] [Related]  

  • 68. Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment.
    Hall VC; Liesegang TJ; Kostick DA; Lookingbill DP
    Arch Dermatol; 2003 Aug; 139(8):1083-4. PubMed ID: 12925404
    [No Abstract]   [Full Text] [Related]  

  • 69. Tacrolimus as a therapeutic alternative in psoriasis: A retrospective observational study.
    Baveja S; Neema S; Pathania V; Kothari R
    Indian J Dermatol Venereol Leprol; 2022; 88(2):247-249. PubMed ID: 34877850
    [No Abstract]   [Full Text] [Related]  

  • 70. Successful treatment of severe recalcitrant erosive oral lichen planus with topical tacrolimus.
    Shichinohe R; Shibaki A; Nishie W; Tateishi Y; Shimizu H
    J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):66-8. PubMed ID: 16405611
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Treatment of ulcerative necrobiosis lipoidica with topical calcineurin inhibitor: case report and literature review.
    Binamer Y; Sowerby L; El-Helou T
    J Cutan Med Surg; 2012; 16(6):458-61. PubMed ID: 23149208
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Juvenile-onset keratosis lichenoides chronica treated successfully with topical tacrolimus: a safe and favourable outcome.
    Oyama N; Mitsuhashi Y; Yamamoto T
    Eur J Dermatol; 2011; 21(4):595-6. PubMed ID: 21659068
    [No Abstract]   [Full Text] [Related]  

  • 73. Topical tacrolimus for effective treatment of eosinophilic folliculitis associated with human immunodeficiency virus infection.
    Toutous-Trellu L; Abraham S; Pechère M; Chavaz P; Lübbe J; Schiffer V; Hirschel B; Saurat JH; Piguet V
    Arch Dermatol; 2005 Oct; 141(10):1203-8. PubMed ID: 16230556
    [No Abstract]   [Full Text] [Related]  

  • 74. [Treatment of erosive oral lichen planus with topical tacrolimus].
    Sun YJ; Sun Z
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Mar; 45(3):182-5. PubMed ID: 20450689
    [No Abstract]   [Full Text] [Related]  

  • 75. Topical tacrolimus in the treatment of atopic dermatitis.
    Gianni LM; Sulli MM
    Ann Pharmacother; 2001; 35(7-8):943-6. PubMed ID: 11485148
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pimecrolimus and tacrolimus: the US FDA public health advisory.
    Maddin S
    Skin Therapy Lett; 2005 May; 10(4):1-3. PubMed ID: 15986080
    [No Abstract]   [Full Text] [Related]  

  • 77. Topical tacrolimus for the treatment of psoriasis on the face, genitalia, intertriginous areas and corporal plaques.
    Martín Ezquerra G; Sánchez Regaña M; Herrera Acosta E; Umbert Millet P
    J Drugs Dermatol; 2006 Apr; 5(4):334-6. PubMed ID: 16673800
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Positive effects of tacrolimus in a case of CIDP.
    Ahlmén J; Andersen O; Hallgren G; Peilot B
    Transplant Proc; 1998 Dec; 30(8):4194. PubMed ID: 9865344
    [No Abstract]   [Full Text] [Related]  

  • 79. Mometasone furoate 0.1% and salicylic acid 5% vs. mometasone furoate 0.1% as sequential local therapy in psoriasis vulgaris.
    Tiplica GS; Salavastru CM
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):905-12. PubMed ID: 19470062
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Psoriasis-associated keratitis: case report].
    Filev FS; Herbert VG; Lögering B; von Gruben V; Reich K; Klemm M
    Ophthalmologe; 2014 Dec; 111(12):1201-3. PubMed ID: 25245022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.